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Abstract
Background: Sevoflurane is one of the most frequently used inhaled anesthetics for general anesthesia. Previously
it has been reported that at clinically used doses of sevoflurane, cerebral vasoreactivity is maintained. However,
there are no data how sevoflurane influences systemic and cerebral circulation in parallel. The aim of our study was
to assess systemic and cerebral hemodynamic changes as well as cerebral CO2-reactivity during sevoflurane
anesthesia.
Methods: Twenty nine patients undergoing general anesthesia were enrolled. Anesthesia was maintained with 1
MAC sevoflurane in 40% oxygen. Ventilatory settings (respiratory rate and tidal volume) were adjusted to reach and
maintain 40, 35 and 30 mmHg EtCO2 for 5 min respectively. At the end of each period, transcranial Doppler and
hemodynamic parameters using applanation tonometry were recorded.
Results: Systemic mean arterial pressure significantly decreased during anesthetic induction and remained
unchanged during the entire study period. Central aortic and peripherial pulse pressure and augmentation index as
markers of arterial stiffness significantly increased during the anesthetic induction and remained stable at the time
points when target CO2 levels were reached. Both cerebral autoregulation and cerebral CO2-reactivity was
maintained at 1 MAC sevoflurane.
Discussion: Cerebral autoregulation and CO2-reactivity is preserved at 1 MAC sevoflurane. Cerebrovascular effects
of anesthetic compounds have to be assessed together with systemic circulatory effects.
Trial registration: The study was registered at http://www.clinicaltrials.gov, identifier: NCT02054143, retrospectively
registered. Date of registration: February 4, 2014.
Keywords: Sevoflurane, Cerebral blood flow, cerebral autoregulation, CO2-reactivity, applanation tonometry,
Transcranial Doppler
Background
The most important vasoregulatory mechanisms deter-
mining brain circulation are cerebral autoregulation and
cerebral vasoreactivity. Cerebral autoregulation is the
inherent ability of the brain circulation to maintain
constant cerebral blood flow during alterations of
systemic blood pressure and cerebral perfusion pressure.
Cerebral vasoreactivity is responsible for enabling to
change the blood flow (either globally or locally) accord-
ing to the metabolic needs of the brain tissue [1]. Ideally,
anesthetic agents should not have any significant impact
on cerebral autoregulation and cerebral vasoreactivity
during general anesthesia, which is especially important
in the neurosurgical practice. There are data indicating
that volatile anesthetics may alter both autoregulation
and cerebral vasoreactivity to carbon-dioxide [2–4]
under general anesthesia. Inhalational agents are usually
characterized by dose-dependent depressive effect on
cerebral autoregulation, with the exception of sevoflurane
[3]. Sevoflurane, the most widely used inhalational agent
does not influence cerebral vasoreactivity at MAC levels
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between 0.3 and 1.5 in healthy individuals [5]. There are
reports suggesting that the autoregulatory plateau is short-
ened under sevoflurane anesthesia with MAC 1, and the
upper and lower limits of autoregulation were independ-
ent of the age of the patients [5].
During induction and maintenance of general
anesthesia different systemic and cerebral effects of the
anesthetic agents have to be taken into account to have
a global view on the anesthetic’s effect and for the inter-
pretation of the results. Thus, in the present study we
aimed to assess changes in cerebral circulation and
peripheral systemic hemodynamic changes in parallel
during induction and maintenance of anesthesia with
sevoflurane and the effect of different hypocapnic levels.
Applanation tonometry, a new, non-invasive method
has been recently reported to be accurate for non-invasive
intraoperative assessment of systemic hemodynamic
changes during general anesthesia [6]. In line with this, for
our measurements we used parallel assessment of
systemic and cerebral circulation with the combination of
applanation tonometry and transcranial Doppler.
We aimed to answer the following study questions:
 What is the effect of anesthetic induction and
reaching the steady state sevoflurane anesthesia on
systemic hemodynamics and cerebral blood flow
measurements?
 Is cerebral autoregulation maintained at
normocapnic steady state 1 MAC sevoflurane
anesthesia?
 What are the cerebral and systemic hemodynamic




After approval from the local Ethics Committee
(DEOEC RKEB/IKEB 3584–2012;), written informed
consent was obtained from 35 ASA I-II patients sched-
uled for varicectomy and inguinal hernial repair surgery.
The study was registered at http://www.clinicaltrials.gov,
identifier: NCT02054143, retrospectively registered.
Exclusion criteria were age < 18 years or > 60 years,
severe cardiovascular disease, severe carotid artery sten-
osis, cerebrovascular disease, smoking, diabetes mellitus,
renal disease, hyperlipidemia, left ventricular hyper-
trophy and severe alteration of the preoperative pulmon-
ary function, characterized as FEV1 < 70% and FEV1/
FVC ≤70% of the predicted value.
Devices and measurements
For applanation tonometry SphygmoCor (AtCor
Medical, Sydney, Australia) device was used. During
applanation tonometry the sensor was placed on the
patient’s skin over the radial artery. This placement ap-
plies pressure on the radial artery and the pressure of
the sensor flattens (i.e., ‘applanates’) the radial artery.
Under optimal ‘applanation conditions’, the transmural
pressure of the radial artery wall is zero and the intra-
luminal applanation tonometry can be recorded by the
sensor. In the present study applanation tonometry pa-
rameters were recorded at the left radial artery. Using
applanation tonometry we registered systolic and dia-
stolic aortic pressure, aortic pulse pressure, peripherial
pulse pressure, augmentation pressure, augmentation
index normalized on actual heart rate (Alx@HR) and
ejection duration. All measurements were performed by
the same experienced operator (DP).
Transcranial Doppler (TCD) measurements were
performed using Rimed Digilite transcranial Doppler
sonography (Rimed Ltd., Israel). The temporal window
was used for insonation of the middle cerebral artery at
45–55mm depth, depending on the best signal. A fixed
probe was used to register systolic, diastolic and mean
blood flow velocities; pulsatility indices were calculated
by the device.
Study protocol
Preoperative measurements were recorded one hour
before anesthetic induction in supine position in quiet
environment. Patients were then premedicated with 7.5
mg midazolam orally 60 min before entering the operat-
ing room. Anaesthesia was induced with a combination
of 2 mg.kg− 1 propofol and 2 μg.kg− 1 fentanyl. Intubation
was facilitated by administration of 0.6 mg.kg− 1 rocuro-
nium. Fentanyl and rocuronium were repeated as
needed. Anesthesia was maintained with sevoflurane in
40% oxygen. The concentration of sevoflurane was
titrated to a target Bispectral Index (BIS) between 40
and 60 (Covidien, Dublin, Ireland) and it was targeted at
1 MAC. Neuromuscular block was monitored with
acceleromyography (TOF Watch SX, NV Organon, Oss,
the Netherlands). Standard monitoring included five-
leads ECG, NIBP, core temperature at the tympanic
membrane, and pulse oximetry. Normothermia was
maintained with forced-air system (Bair Hugger 750, 3
M, Eden Prairie, MN, USA).
Patients were ventilated using volume-controlled
square-wave flow pattern ventilation with 6–8 mL.kg− 1
TV, 5 cmH2O PEEP, 2 L.min
− 1 fresh gas flow and with a
respiratory rate adjusted to reach and maintain 40
mmHg EtCO2 (Draeger Primus anesthesia workstation,
Draeger Lübeck, Germany).
After induction of general anaesthesia and intubation,
lungs were ventilated in supine position for 20 min as
described above. At this stage, hemodynamic, transcra-
nial Doppler, applanation tonometry and ventilatory
parameters were simultaneously recorded.
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In the second phase of the study minute ventilation
(respiratory rate and tidal volume) was changed to reach
and maintain 35 mmHg EtCO2. After 5 min stabilisation
period all measurements were repeated.
At the next stage of measurement series ventilatory
settings were again changed to reach and maintain 30
mmHg EtCO2 After a 5 min stabilisation period, appla-
nation tonometry and transcranial Doppler measure-
ments were repeated. The flow chart of the study is
summarized in Fig.1.
During each measurement pulse oxygen saturation
(SpO2), heart rate, systolic and diastolic blood pressure,
bispectral index values, systolic, diastolic and mean
blood flow velocities and pulsatility indices in the middle
cerebral artery, systolic and diastolic aortic pressure,
aortic pulse pressure, peripherial pulse pressure,
augmentation pressure, Alx@HR, ejection duration and
operation index were registered.
The entire study and its interpretation follows the
CONSORT guidelines.
Statistical methods
Before starting the study, a power analysis was
performed to calculate the necessary number of patients
to be included. We hypothesized that sevoflurane will
not affect cerebral CO2-reactivity at 1 MAC (primary
end point). Based on our previous study performed
among non-anesthetized individuals, we found that
hyperventilation lasting for 1 min results in a decrease of
PCO2 by 7 mmhHg, accompanied by a 26.7 cm/s
decrease of the middle cerebral artery mean blood flow
velocity [7]. Accordingly, we calculated that 1 mmHg
decrease of PCO2 results in a 3.84 cm/s change in blood
flow velocity. As per protocol we intended to decrease
CO2 by 10 mmHg in 2 steps, we calculated with a 38.4
cm/s (30 cm/s standard deviation) change, with a power
of 0.9 and with an alpha of 0.01. Our power calculation
indicated that 12 patients need to be included to test
our hypothesis. As both registration methods may be
operator-dependent, for sake of clarity we decided to in-
clude 30 patients. The normality of distribution of data
was tested by Shapiro–Wilks test. Thereafter, differences
were analyzed with the Repeated Measures Analysis of
Variance (ANOVA) with Bonferroni post hoc correction.
Values of p < 0.05 were accepted as statistically
significant. Data are presented as mean (SD). MedCalc
Statistical Software version 18.2.1. (MedCalc Software
bvba, Ostend, Belgium) was used for statistical analy.
Results
Demographic data
Twenty-nine patients were enrolled aged 19–58
(mean 37), 17 female, 12 male. 7 patients underwent
inguinal hiatal repair surgery, while 22 varicetomy. 1
patient was excluded due to inapproriate temporal
window for TCD.
Respiratory parameters and anesthetic depth during the
procedure
During the course of the study ventilatory settings were
changed at different stages of the study to reach and
maintain different levels of EtCO2 (40, 35 and 30 mmHg
respectively). Accordingly, there were significant differ-
ences in values of tidal volumes, respiratory rates. BIS
values were stable during the entire procedure indicating
adaequate depth of anesthesia (Table 1).
Hemodynamic parameters
There were no significant differences neither in systolic
blood pressure values, nor in heart rate during the
course of the study. In contrast, there were significant
differences in diastolic blood pressure: preoperative
Fig. 1 Flow chart of the study
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values were significantly higher than values measured in
any other timepoints (Table 2).
Applanation tonometry parameters
Mean arterial pressure significantly decreased during in-
duction of anesthesia, reaching a steady state and
remained stable during the entire course of the study. In
parallel, aortic and peripheral pulse pressures both in-
creased during the induction phase as did the augmenta-
tion index. All parameters remained unchanged during
the next phases of the study (Fig. 2).
Transcranial Doppler sonography parameters
Preoperative middle cerebral artery mean blood flow
velocity values were not significantly different from
values measured at steady state sevoflurane stage under
normocapnic conditions (EtCO2 40mmHg). However,
mean blood flow velocity values measured during EtCO2
35 and 30 mmHg were significantly different form each
other as well as from preoperative and values measured
at EtCO240 (Fig. 3). Pulsatility index values did not
change during induction phase and reaching the steady
state, however they significantly increased along with the
decreased EtCO2 values (Fig. 4.). There was a strong
significant correlation between Vmean and EtCO2 values
(p < 0.001, Pearson’s r = 0.79).
Relationship between mean arterial pressure and cerebral
blood flow velocity changes after induction and
stabilisation of anesthesia
We assessed the percent change between mean arterial
pressure and middle cerebral artery mean blood flow vel-
ocity before anesthetic induction and 20min after
anesthesia was induced and a steady state of sevoflurane
anesthesia was reached at normocapnic PCO2 (40mmHg).
As shown in Fig. 5, there was a significant linear
relationship between the two parameters, indicating
preserved static autoregulation of the cerebral circulation
at normocapnic steady state of sevoflurane anesthesia.
Discussion
Anesthetic agents may have various effects on systemic
circulation determining the cerebral perfusion pressure.
Additionally, whyle using some agents, direct cerebral
effect has also to be taken into account. Both effects are
dose-dependent and are exerted through vasodilation or
vasoconstriction of the cerebral vessels (medium-size
vessels and arterioles), as well as through decreasing
CMRO2 - thus influencing flow-metabolism coupling of
the brain tissue. The main actors of this systemic and
cerebral effects are cerebral arterioles, that are respon-
sible for autoregulatory reactions during changes of
cerebral blood flow and vasoreactivity related to meta-
bolic changes [1]. Consequently, for sake of clarity, all
the possible influencing factors (systemic and metabolic
factors) have to be assessed in parallel while it is
intended to test the effect of an anesthetic agent on
cerebral blood flow, cerebral autoregulation and cerebral
vasoreactivity. The proposed mechanisms of action of
general anesthetics on cerebral circulation are summa-
rized at Fig. 6.
Previous reports indicated that sevoflurane between
0.5–1.0 MAC has minimal direct vasodilatory effect on
the brain arteries [8, 9] and has no systemic
hemodynamic effects (cardiac contractility and/or
peripheral vascular resistance) at the most frequently
used 1 MAC sevoflurane [10]. In the present study, dur-
ing the induction phase, the combination of propofol-
fentanyl-rocuronium and adding sevoflurane resulted in
a decreased mean arterial pressure (mainly due to the
decrease of the diastolic pressure) and an increase in
aortic and pulse pressure. During the later phases of
anesthesia, however no significant changes occurred in
any of the hemodynamic parameters (mean arterial pres-
sure, aortic pressure, pulse pressure and augmentation
index), indicating no systemic effects of sevoflurane. It is
conceivable that the peripheral vasodilation oserved
during the induction phase can be mainly ascribed to
the use of propofol.
We found that reaching the stady state under sevoflur-
ane anesthesia resulted in a decrease of the mean arterial
pressure leading to non significant change in the
Table 1 Hemodynamic parameters during the course of the study
ETCO2 40 ETCO2 35 ETCO2 30 p
Tidal volume 516 (64) 550 (63)‡‡‡ 570 (88)‡‡‡ p < 0.001
Respiratory rate 9 (2)††† 12 (13) ‡‡‡ 15 (3)‡‡‡, ††† p < 0.001
BIS 42 (2) 42 (1) 42 (2) p = 0.75
Data are presented as mean (SD) *: Significant difference compared to
preoperative values ‡: Significant difference compared to EtCO2 40 values
†: Significant difference compared to EtCO2 35 values,
#: Significant difference
compared to EtCO2 30 values, *
, †, #, ‡ indicates p < 0.05; **, ††, ##, ‡‡ indicates
p < 0.01; ***, †††, ###, ‡‡‡ indicates p < 0.001
Table 2 Hemodynamic parameters during the course of the study
Preop ETCO2 40 ETCO2 35 ETCO2 30 p
Systolic blood pressure 109 (29) 106 (8) 108 (9) 108 (9) p = 0.46
Diastolic blood pressure 81 (9) 65 (10)*** 67 (10)*** 66 (11)*** p < 0.001
Heart rate 67 (10) 70 (12) 67 (11) 69 (12) p = 0.38
Data are presented as mean (SD), *: Significant difference compared to preoperative measured values, *** indicates p < 0.001
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cerebral blood flow velocity. Cerebral autoregulation is
defined as the inherent ability of the brain circulation to
maintain a constant cerebral blood flow during changes
of cerebral perfusion pressure [1]. In line with this, we
checked the relationship between %-changes of MAP
and cerebral blood flow velocity values and found a
linear relationship between the two factors, indicating
preserved autoregulation. While mean arterial pressure
decreased, cerebral blood flow velocity remained
unchanged during the induction phase and reaching the
steady state. As demonstrated in Fig. 5., pulsatility index
(representing the vascular resistance of the cerebral arte-
rioles) significantly decreased during this period enabling
unchanged cerebral blood flow during the decrease of
MAP.
Carbon-dioxide reactivity of the cerebral circulation is
defined as the change in cerebral blood flow velocity per
mmHg change in PCO2. In previous volunteer studies it
has been demonstrated that forced hyperventilation
lasting for 60 s results in a 38% percent decrease of the
middle cerebral artery mean flood flow velocity
Fig. 2 Applanation tonometry parameters at rest and during the course of the study. Medians and CI values are shown. * indicates p < 0.05
difference as compared to steady state values
Fig. 3 Changes of middle cerebral artery mean blood flow velocity
(MCAV) during the course of the study. Medians and CI values are
shown. ** indicates p < 0.01, *** indicates p < 0.001 differences as
compared to steady state values
Juhász et al. BMC Anesthesiology          (2019) 19:109 Page 5 of 8
compared to the resting BFV [7]. The accepted normal
values for CO2-reactivity is 2–5 cm/s/mmHg [4]. In the
present study a decrease of PCO2 from 40mmHg to 35
mmHg resulted in an average decrease of mean blood
flow velocity of 4 cm/s/mmHg, whereas to 30 mmgHg
PCO2 resulted in a decrease of 8 cm/s/mmHg. These
values correspond to the previous observations and
indicate preserved CO2-reactivity during sevoflurane
anesthesia at MAC 1 concentrations.
Both cerebral autoregulation and cerebral vasoreac-
tivity are multifactorially determined defending mech-
anisms of the brain that aim to optimize global and
cerebral circulation according to the actual metabolic
needs. The main actors of these two mechanisms are
cerebral arterioles, roughly 200 μm in diameter [1].
The patency of autoregulatory and vasoreactivity reac-
tions depends on systemic factors (such as cerebral
perfusion pressure), local metabolic demands as well
Fig. 4 Changes of pulsatility index during the course of the study. Medians and CI values are shown. * indicates p < 0.05, *** indicates p < 0.001
differences as compared to steady state values
Fig. 5 Relationship between the %change of mean arterial pressure (MAP) and middle cerebral artery mean blood flow velocity (MCAV) after
anesthetic induction and reaching the steady state
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as underlying diseases of the patients. Previously it
has been demonstrated that cerebral autoregulation
and reactivity of the cerebral vessels to induced hypo-
capnia may be impaired in patients with certain
underlying diseases, such as hypertension and diabetes
mellitus [11–14]. As a consequence, sudden intraoper-
ative changes of cerebral perfusion pressure and/or
carbon-dioxide concentration may challenge the auto-
regulatory and metabolic regulatory responses and
thus may result in critical brain tissue oxygenation. In
line with our observations, previous studies in
humans also demonstrated that sevoflurane at ≤1
MAC concentrations does not affect cerebral autoreg-
ulation [15–17]. In a very recent study Sperna
Weiland and co-workers found that sevoflurane does
not affect the already impaired cerebral autoregulation
in diabetic patients at clinicially applied doses [18].
Finally, we have to mention the limitations of our
study. The methodological limitations are that trans-
cranial Doppler does not measure cerebral blood flow,
only changes of the blood flow velocities are propor-
tional to cerebral blood flow values. Applanation to-
nometry that was used for monitoring the systemic
hemodynamic effect is operator-dependent procedure.
Therefore all measurements were performed by the
same, experienced physician (DP). And finally, in the
present study we only tested CO2-reactivity toward
hypocapnic direction. This was done intentionally, as
in the usual practice normocapnia is maintained dur-
ing anesthesia and in specific neuroanesthetic cases
only induced hypocapnia is used as the part of the
intracranial pressure decreasing strategy.
Conclusion
Sevoflurane at clinically administered doses does not
have any significant systemic hemodynamic effects and
does not influence static cerebral autoregulation and
cerebrovascular reactivity.
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